Analytical Data
-
Gene name
TDGF1P3
- Application
-
Alternative Names
TDGF1P3；CRIPTO-3；TDGF1P3；TDGF2；Putative Protein CRIPTO3
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P51864
-
Expression Region
31-188aa
-
AA Sequence
LGHQEFARPSRGDLAFRDDSIWPQEEPAIRPRSSQRVLPMGIQHSKELNR TCCLNGGTCMLESFCACPPSFYGRNCEHDVRKENCGSVPHDTWLPKKCSL CKCWHGQLRCFPQAFLPGCDGLVMDEHLVASRTPELPPSARTTTFMLAGI CLSIQSYY
-
Molecular Weight
21.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TDGF1P3, also known as teratocarcinoma-derived growth factor 1 protein 3, is a novel protein that has garnered attention in the field of regenerative medicine and cancer biology. Its discovery stems from investigations into the molecular mechanisms underlying various developmental processes and tumorigenesis. Research indicates that TDGF1P3 may play a role in cell differentiation and tissue regeneration, particularly in embryonic stem cells and teratocarcinomas. The protein's expression patterns suggest it could be involved in signaling pathways that regulate cell growth and apoptosis, making it a potential candidate for therapeutic applications in cancer treatment and tissue engineering. Furthermore, studies have shown that TDGF1P3 interacts with other key cellular proteins, hinting at its functional importance in maintaining cellular homeostasis and responding to environmental stimuli. As such, uncovering the biological roles and regulatory mechanisms of TDGF1P3 could provide valuable insights into its potential as a biomarker for cancer prognosis and a target for novel therapeutic strategies. Continued research into this recombinant protein may lead to breakthroughs in understanding complex biological processes and developing innovative treatments for various diseases.
